Trifecta Capital Advisors LLC trimmed its position in shares of Align Technology, Inc. (NASDAQ:ALGN – Free Report) by 9.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,946 shares of the medical equipment provider’s stock after selling 210 shares during the quarter. Trifecta Capital Advisors LLC’s holdings in Align Technology were worth $495,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds also recently modified their holdings of ALGN. Kayne Anderson Rudnick Investment Management LLC boosted its holdings in shares of Align Technology by 4,391.3% in the 2nd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 488,251 shares of the medical equipment provider’s stock worth $117,879,000 after acquiring an additional 477,380 shares in the last quarter. Swedbank AB acquired a new position in Align Technology in the first quarter worth $96,117,000. Bares Capital Management Inc. grew its holdings in shares of Align Technology by 44.4% during the first quarter. Bares Capital Management Inc. now owns 819,930 shares of the medical equipment provider’s stock worth $268,871,000 after purchasing an additional 252,220 shares during the last quarter. Point72 Asset Management L.P. increased its stake in shares of Align Technology by 127.4% in the second quarter. Point72 Asset Management L.P. now owns 343,512 shares of the medical equipment provider’s stock valued at $82,934,000 after buying an additional 192,474 shares in the last quarter. Finally, Jacobs Levy Equity Management Inc. increased its stake in shares of Align Technology by 371.0% in the first quarter. Jacobs Levy Equity Management Inc. now owns 218,779 shares of the medical equipment provider’s stock valued at $71,742,000 after buying an additional 172,330 shares in the last quarter. Institutional investors and hedge funds own 88.43% of the company’s stock.
Insider Buying and Selling
In other news, Director C Raymond Larkin, Jr. bought 6,500 shares of the stock in a transaction on Thursday, August 15th. The stock was purchased at an average price of $235.33 per share, with a total value of $1,529,645.00. Following the completion of the purchase, the director now owns 28,247 shares of the company’s stock, valued at approximately $6,647,366.51. This trade represents a 0.00 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. 0.62% of the stock is owned by insiders.
Analyst Ratings Changes
Read Our Latest Stock Report on Align Technology
Align Technology Stock Performance
ALGN opened at $216.02 on Friday. The company has a fifty day moving average price of $234.48 and a two-hundred day moving average price of $254.22. The firm has a market capitalization of $16.26 billion, a PE ratio of 35.59, a P/E/G ratio of 5.33 and a beta of 1.64. Align Technology, Inc. has a 52 week low of $176.34 and a 52 week high of $335.40.
Align Technology (NASDAQ:ALGN – Get Free Report) last announced its quarterly earnings data on Wednesday, July 24th. The medical equipment provider reported $2.41 EPS for the quarter, topping analysts’ consensus estimates of $2.32 by $0.09. The business had revenue of $1.03 billion during the quarter, compared to analysts’ expectations of $1.04 billion. Align Technology had a return on equity of 14.07% and a net margin of 11.34%. The firm’s quarterly revenue was up 2.6% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.73 earnings per share. Equities analysts forecast that Align Technology, Inc. will post 7.61 EPS for the current year.
Align Technology Company Profile
Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.
Featured Articles
- Five stocks we like better than Align Technology
- What Are the U.K. Market Holidays? How to Invest and Trade
- Taiwan Semiconductor Soars on Earnings With More Room to Run
- How to buy stock: A step-by-step guide for beginners
- Is Lucid Group Nearing the Bottom? What Investors Should Know
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- 90% Gain Possible? Analysts Are Bullish on Joby Aviation
Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.